Health
Experimental ALS drug shows potential to prolong patient survival – News-Medical.Net
An experimental medication that was recently shown to slow the progression of the neurodegenerative disease amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s…
Reviewed by Emily Henderson, B.Sc.Oct 16 2020
An experimental medication that was recently shown to slow the progression of the neurodegenerative disease amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, has now demonstrated the potential to also prolong patient survival. The findings come from a clinical trial conducted by investigators at the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital (MGH) and Amylyx Pharmaceuticals, Inc., the company that manufactu…
-
Noosa News23 hours agoQueensland government to introduced artificial intelligence teaching tool Corella to all state high schools
-
Noosa News22 hours agoMan charged with murder three days after death of 27-year-old in Livingstone, QLD
-
Business14 hours agoThe pros and cons of buying CBA shares in September
-
Noosa News14 hours agoRent changes on way for hundreds of social housing recipients following government review